Research & Development



  關上大門,雲氏就是另一個天地。   劉陵輕笑道︰“這是單于愛護我。”超碰人人最新上线 青青草视频   雲瑯隨意的將手里的瓷盤子丟在桌子上道︰“我請你吃人世間少有的美味,你卻把注意力放在泥土燒制成的盤子上,未免有些暴殄天物。”   “我們要放棄漠南嗎?”有人顫聲問道。青青草视频免费观看   阿嬌沒有再勸劉徹吃東西,今天難得吃一口,已經算是破例了,如何能夠再強求。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo